Specific modulation of the fusogenic properties of the Alzheimer β-amyloid peptide by apolipoprotein E isoforms

European Journal of Biochemistry

Volumn 243, Issue 3, 1997, Pages 650-659

  Pillot, T ^a   Goethals, M ^a   Vanloo, B ^a   Lins, L ^a   Brasseur, R ^a   Vandekerkckhove, J ^a   Rosseneu, M ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Aggregation; Alzheimer amyloid peptide; Apolipoprotein E; Membrane fusion; Synthetic peptide

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; HYBRID PROTEIN; LIPOSOME; PROTEIN DERIVATIVE; VIRUS PROTEIN;

ALZHEIMER DISEASE; ARTICLE; DOSE RESPONSE; DRUG COMPARISON; FLUORESCENCE; GEL ELECTROPHORESIS; HUMAN; IN VITRO STUDY; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PROTEIN INTERACTION;

EID: 0031037086     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1997.00650.x     Document Type: Article

References (40)

1. Aggerbeck, L. P., Wetterau, J. R., Weisgraber, K. H., Wu, C.‐S. C. & Lindgren, F. T. (1988) Human apolipoprotein E3 in aqueous solution. 11. Properties of the amino‐ and carboxyterminal domains, J. Biol. Chem. 263, 6249–6258.
2. Arispe, N., Pollarde, H. B. & Rojas, E. (1993a) Giant multilevel cation channels formed by Alzheimer disease amyloid β‐protein (AβP‐(1–40)) in bilayer membranes, Proc. Natl Acad. Sci. USA 90, 10573–10577.
3. Arispe, N., Pollarde, H. B. & Rojas, E. (1993b) Alzheimer disease amyloid β‐protein forms calcium channels in bilayer membranes: blockage by tromethanine and aluminium, Proc. Natl Acad. Sci. USA 90, 567–571.
4. Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C. & Glabe, C. (1992) Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs, J. Biol. Chem. 267, 546–554.
5. Come, J. H., Fraser, P. E. & Lansbury, P. T. (1993) A kinetic model for amyloid formation in the prion diseases: importance of seeding, Proc. Natl Acad. Sci. USA 90, 5959–5963.
6. De Pauw, M., Vanloo, B., Weisgraber, K. H. & Rosseneu, M. (1995) Comparison of lipid‐binding and lecithin: cholesterol acyltransferase activation of the amino‐ and carboxy‐terminal domains of human apolipoprotein E3, Biochemistry, 34, 10953–10960.
7. Dong, L. M., Parkin, S., Trakhanov, S. D., Rupp, B., Simmons, T., Arnold, K. S., Newhouse, Y. M., Innerarity, T. L. & Weisgraber, K. H. (1996) Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia, Nature Struct. Biol. 3, 718–722.
8. Evans, K. C., Berger, E. P., Cho, C. G., Weisgraber, K. H. & Lansbury, P. T. (1995) Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer's disease, Proc. Natl Acad. Sci. USA 92, 763–767.
9. Halverson, K., Fraser, P. E., Kirschner, D. A. & Lansbury, P. T. (1990) Molecular determinants of amyloid deposition in Alzheimer's disease: conformational studies of synthetic b‐protein fragments, Biochemistry 29, 2639–2644.
10. Hilbich, C., Kisters‐Woike, B., Reed, J., Masters, C. L. & Beyreuther, K. (1991) Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease, J. Mol. Biol. 218, 149–163.
11. Horth, M., Lambrecht, B., Khim, M. C. L., Bex, F., Thiriard, C., Ruysschaert, J. M., Burny, A. & Brasseur, R. (1991) Theoretical and functional analysis of the SIV fusion peptide, EMBO J. 10, 2747–2755.
12. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227, 680–685.
13. Lansbury, P. T., Costa, P. R., Griffiths, J. M., Simon, E. J., Auger, M., Halverson, K. J., Kocisko, D. A., Hendsch, Z. S., Ashburn, T. T., Spencer, R. G. S., Tidor, B. & Griffin, R. G. (1995) Structural model for the β‐amyloid fibril based on interstrand aligment of an anti‐parallel‐sheet comprising a C‐terminal peptide, Nat. Struct. Biol. 2, 990–998.
14. Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. (1951) Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193, 265–275.
15. Martin, I., Dubois, M. C., Saerkman, T. & Ruysschaert, J. M. (1992) Apolipoprotein A‐I interacts with the N‐terminal fusogenic domains of SIV (Simian Immunodeficiency Virus) GP32 and HIV (Human Immunodeficiency Virus) GP41: implications in viral entry, Biochem. Biophys. Res. Commun. 186, 95–101.
16. Mattson, M. P. (1995) Untangling the pathophysiochemistry of β‐amyloid, Nat. Struct. Biol. 2, 926–928.
17. Morris, S. J., Bradley, D., Gibson, C. C., Smith, P. D. & Blumenthal, R. (1988) Use of membrane‐associated fluorescence probes to monitor fusion of bilayer vesicles: application to rapid kinetics using pyrene excimer/monomer fluorescence, in Spectroscopic membrane probes ( Loem, L. M., ed.) pp. 161–191, CRC Press, Boca Raton FL.
18. Pike, C. J., Burdick, D., Walencewicz, A. J., Glabe, C. G. & Cotman, C. W. (1993) Neurodegeneration induced by beta‐amyloid peptides in vifro: the role of peptide assembly state, J. Neurosci. 13, 1676–1687.
19. Pillot, T., Goethals, M., Vanloo, B., Talussot, C., Brasseur, R., Rosseneu, M., Vandekerckhove, J. & Lins, L. (1996a) Fusogenic properties of C‐terminal domains of the Alzheimer β‐amyloid peptide, J. Biol. Chem. 271, 28757–28765.
20. Pillot, T., Barbier, A., Visvikis, A., Lozac'h, K., Rosseneu, M., Vandekerckhove, J. & Siest, G. (1996b) Single step purification of two functional apolipoprotein E variants hyperexpressed in E. coli, Protein Express. Purif 7, 407–414.
21. Pitas, R. E., Boyles, J. K., Lee, S. H., Hui, D. & Weisgraber, K. H. (1987) Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E(LDL) receptors in the brain, J. Biol. Chem. 262, 14352–14360.
22. Rapaport, D. & Shai, Y. (1994) Interaction of fluorescently labeled analogues of the amino‐terminal fusion peptide of Sebdai Virus with phospholipid membranes, J. Biol. Chem. 269, 15124–15131.
23. Schubert, D., Behl, C., Lesley, R., Brack, A., Dargusch, R., Sagara, Y. & Kimura, H. (1995) Amyloid peptides are toxic via a common oxidative mechanism, Proc. Natl Acad. Sci. USA 92, 1989–1993.
24. Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Too, S. H., Pericak‐Vance, M.‐A., Goldgaber, D. & Roses, A. D. (1993) Increase amyloid p‐peptide deposition in cerebral cortex as a consequence of apoliprotein E genotype in late‐onset Alzheimer disease, Proc. Natl Acad. Sci. USA 90, 9649–9653.
25. Selkoe, D. J. (1994) Amyloid β‐protein precursor: new clues to the genesis of Alzheimer's disease, Cum Opin. Neurobiol. 4, 708–716.
26. Srinivas, R. V., Birkedal, B., Owens, R. J., Anantharamaiah, G. M., Segrest, J. P. & Compans, R. W. (1990) Antiviral effects of apolipoprotein A‐1 and its synthetic amphipathic peptide analogs, Virology 176, 48–57.
27. Strittmatter, W. J., Saunders, A., Schmechel, D., Pericak‐Vance, M., Englhild, J., Salvesen, O. S. & Roses, A. D. (1993a) Apolipoprotein E: high‐avidity binding to [hmyloid and increased frequency of type 4 allele in late‐onset familial Alzheimer disease, Proc. Natl Acad. Sci. USA 90, 1977–1981.
28. Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak‐Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D. & Roses, A. D. (1993b) Binding of human apolipoprotein E to synthetic amyloid beta‐peptide: isoform‐specific effects and implications for late‐onset Alzheimer disease, Proc. Natl Acad. Sci. USA 90, 8098–8102.
29. Vanloo, B., Morrison, J., Fidge, N., Lorent, G., Lins, L., Brasseur, R., Ruysschaert, J. M., Baert, J. & Rosseneu, M. (1991) Characterization of discoidal complexes formed between apoA‐I‐CNBr fragments and phosphatidylcholine, J. Lipid Res. 32, 1253–1264.
30. Vanloo, B., Taveirne, J., Baert, G., Lorent, G., Vercaemst, R., Lins, L., Ruysschaert, J. M. & Rosseneu, M. (1992) Activation of lecithin cholesterol acyl transferase (LCAT) by the CNBr fragments of human apo AI and conversion of the discoidal complexes into spherical particles, Biochim. Biophys. Acta 1128, 258–266.
31. Vonèche, V., Portetelle, D., Kettman, R., Willemms, L., Limbach, K., Paoletti, E., Ruysschaert, J. M., Burny, A. & Brasseur, R. (1992) Fusogenic segments of bovine leukemia virus and simian immunodeficiency virus are interchangeable and mediate fusion by means of oblique insertion in the lipid bilayer of their target cells, Proc. Natl Acad. Sci. USA 89, 3810–3814.
32. Weisgraber, K. H. (1994) Apolipoprotein E: Structure‐function relationship, Adv. Protein Chem. 45, 249–295.
33. Weisgraber, K. H., Roses, A. D. & Strittmatter, W. J. (1994) The role of apolipoprotein E in the nervous system, Curr: Opin. Lipidol. 5, 110–116.
34. Weiss, J. H., Pike, C. J. & Cotman, C. W. (1994) Ca 2+ channel blockers attenuate β‐amyloid peptide toxicity to cortical neurons in culture, J. Neurochem. 62, 372–375.
35. Westerlund, J. A. & Weisgraber, K. H. (1993) Discrete carboxyl‐terminal segments of apolipoprotein E mediate lipoprotein association and protein oligomerization, J. Biol. Chem. 268, 15745–15750.
36. Whitson, J. S., Mims, M. P., Strittmatter, W. J., Yamaki, T., Morrisset, J. D. & Appel, S. H. (1994) Attenuation of the neurotoxic effect of Aβ amyloid peptide by apolipoprotein E, Biochem. Biophys. Res. Commun. 199, 163–170.
37. Wilson, C., Wardell, M. R., Weisgraber, K. H., Mahley, K. W. & Agard, D. A. (1991) Three‐dimensional structure of the LDL receptor‐binding domain of human apolipoprotein E, Science 252, 1817–1822.
38. Wisniewski, T. & Frangione, B. (1992) Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid, Neurosci. Lett. 135, 235–238.
39. Wisniewski, T., Golabek, A. A., Kida, E., Wisniewski, K. E. & Frangione, B. (1995) Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis, Am. J. Pathol. 147, 238–244.
40. Zimmerberg, J., Vogel, S. S. & Chernomordik, L. V. (1993) Mechanism of membrane fusion, Annu. Rev. Biophys. Biomol. Struct. 22, 433–466.